Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gliosarcoma 31 Glioblastoma 30 Sarcoma 22 Rhabdomyosarcoma 8 Brain Neoplasms 7 Astrocytoma 7 Central Nervous System Neoplasms 6 Melanoma 4 Liposarcoma 4 Histiocytoma, Malignant Fibrous 4 Glioma 4 Bone Neoplasms 4 Sarcoma, Synovial 3 Sarcoma, Ewing 3 Rhabdomyosarcoma, Embryonal 3 Osteosarcoma 3 Neoplasm Metastasis 3 Leiomyosarcoma 3 Breast Neoplasms 3 Rhabdomyosarcoma, Alveolar 2 Prostatic Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neurofibrosarcoma 2 Neoplasms 2 Medulloblastoma 2 Dermatofibrosarcoma 2 Carcinoma, Merkel Cell 2 Vulvar Neoplasms 1

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 Cetuximab 3 pembrolizumab 2 palbociclib 2 Specimen Handling 2 Radiotherapy 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 tazemetostat 1 spartalizumab 1 relatlimab 1 nilotinib 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Photochemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Radiation × Sarcoma × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡